MST-312 (Synonyms: Telomerase Inhibitor IX) |
| Catalog No.GC18769 |
DB2115 (tertachlorhydrate) est un puissant inhibiteur du régulateur maÎtre myéloÏde PU.1. DB2115 (tertachlorhydrate) a le potentiel de rechercher des cancers, y compris des cancers hématologiques tels que la leucémie, ainsi que d'autres conditions associées À l'UP. 1 dysfonctionnement (extrait du brevet WO2017223260A1, composé DB2115) .
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 368449-04-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
MST312 is a telomerase inhibitor (IC50 = 0.67 μM in a TRAP assay). It is selective for telomerase over DNA polymerase when used at concentrations up to 3 μM. MST312 inhibits growth of U937 cells via telomere shortening (GI50 = 1.7 μM). It reduces cell number and expression of the proliferation marker MIB-1 as well as increases DNA damage in primary pediatric ependymoma tumor cells. MST312 decreases survival of H460 and H1299 non-small cell lung cancer (NSCLC) cells in a dose-dependent manner with a greater effect on the aldehyde dehydrogenase positive (ALDH+) cancer stem cell population. In vivo, MST312 (40 mg/kg) reduces tumor size by 70% in an H460 mouse xenograft model. MST312 also inhibits replication of herpes simplex virus 2 (HSV-2) and a clinical isolate of HSV-1 and decreases accumulation of early and late viral proteins in HEp-2 cells infected with HSV-1.
Review for MST-312
Average Rating: 5 (Based on Reviews and 9 reference(s) in Google Scholar.)
Review for MST-312
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *